The Kaplan–Meier analysis showed that patients with WNT-activated medulloblastomas CTNNB1 wild type had worse outcome, with 71.4% of overall survival compared to 100% of CTNNB1 mutant cases (log rank: p=0.031) (Figure 3). The gene discussed is CTNNB1; the disease is medulloblastoma.